• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Schlorff Eric was granted 60,248 shares, increasing direct ownership by 8% to 837,823 units (SEC Form 4)

    11/29/23 4:15:25 PM ET
    $LMAO
    Consumer Electronics/Appliances
    Industrials
    Get the next $LMAO alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Schlorff Eric

    (Last) (First) (Middle)
    C/O SEASTAR MEDICAL HOLDING CORPORATION
    3513 BRIGHTON BLVD., SUITE 410

    (Street)
    DENVER CO 80216

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    SeaStar Medical Holding Corp [ ICU ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    X Officer (give title below) Other (specify below)
    Chief Executive Officer
    3. Date of Earliest Transaction (Month/Day/Year)
    11/29/2023
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock, par value $0.0001 per share 11/29/2023 A 60,248(1) A $0 837,823 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Stock Option (Right to Buy) $1.84 (2) 04/06/2033 Common Stock 99,724 99,724 D
    Stock Option (Right to Buy) $10 (3) 03/01/2029 Common Stock 17,986 17,986 D
    Stock Option (Right to Buy) $0.53 (4) 02/20/2030 Common Stock 83,985 83,985 D
    Explanation of Responses:
    1. The securities reported in this transaction were issued to the Reporting Person in lieu of cash compensation previously approved by the Compensation Committee.
    2. All options reported herein will vest, subject to continued service, on April 6, 2024, the first anniversary of the date of grant.
    3. These options are fully vested.
    4. The option vests with respect to (i) twenty-five percent (25%) of the shares upon completion of one (1) year of service measured from February 20, 2020 and (ii) the balance of the shares subject to the option in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service over the thirty-six (36)-month period measured from February 20, 2021.
    /s/ Eric Schlorff 11/29/2023
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $LMAO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LMAO

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $LMAO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Van Heel Kenneth bought $40,000 worth of shares (100,000 units at $0.40), increasing direct ownership by 610% to 116,400 units (SEC Form 4)

    4 - SeaStar Medical Holding Corp (0001831868) (Issuer)

    11/27/23 4:05:14 PM ET
    $LMAO
    Consumer Electronics/Appliances
    Industrials

    $LMAO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SeaStar Medical (NASDAQ: ICU) Commences Trading on Nasdaq Capital Market and Outlines Corporate Strategy and Near-Term Catalysts

    – Company advancing clinically proven platform therapy, the Selective Cytopheretic Device (SCD), to address the life-threatening consequences of hyperinflammation – SCD lead program in Acute Kidney Injury (AKI) with potential FDA approval for pediatric AKI targeted for Q1 2023 and commencement of pivotal trial in adult AKI targeted in Q1 2023 – Ongoing exploratory clinical research to refine patient populations where SCD may be effective to fuel pipeline with potential in high-value hyperinflammatory indications– SeaStar Medical commenced trading on Nasdaq under the ticker "ICU" today, Monday, October 31st Denver, Colorado, Oct. 31, 2022 (GLOBE NEWSWIRE) -- SeaStar Med

    10/31/22 9:25:47 AM ET
    $LMAO
    Consumer Electronics/Appliances
    Industrials

    SeaStar Medical Completes Business Combination with LMF Acquisition Opportunities

    LMF Acquisition Opportunities Renamed SeaStar Medical Holding Corporation SeaStar Medical Holding Corporation Common Stock and Warrants to Commence Trading on Nasdaq Under New Ticker Symbol "ICU" and "ICUCW" DENVER and TAMPA, Fla., Oct. 28, 2022 (GLOBE NEWSWIRE) -- SeaStar Medical, Inc., a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, today announced that it has completed its previously announced business combination with LMF Acquisition Opportunities, Inc. (NASDAQ:LMAO) (LMAO), a special purpose acquisition company sponsored by LM Funding America, Inc. (NASDAQ:LMFA). The business combination closed on October

    10/28/22 1:20:32 PM ET
    $LMAO
    $LMFA
    Consumer Electronics/Appliances
    Industrials
    Finance: Consumer Services
    Finance

    LMF Acquisition Opportunities, Inc. Stockholders Approve Previously Announced Business Combination with SeaStar Medical, Inc.

    DENVER and TAMPA, Fla., Oct. 18, 2022 (GLOBE NEWSWIRE) -- LMF Acquisition Opportunities, Inc. (NASDAQ:LMAO) (LMAO), a special purpose acquisition company sponsored by LM Funding America, Inc. (NASDAQ:LMFA), and SeaStar Medical, Inc., a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, today announced that LMAO stockholders voted to approve the previously proposed business combination with SeaStar Medical at LMAO's special meeting of LMAO stockholders (the "Special Meeting") held earlier today, October 18, 2022. More than 96% of the votes cast at the meeting voted to approve the business combination with SeaStar Med

    10/18/22 6:00:00 PM ET
    $LMAO
    $LMFA
    Consumer Electronics/Appliances
    Industrials
    Finance: Consumer Services
    Finance

    $LMAO
    SEC Filings

    View All

    LMF Acquisition Opportunities Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement

    8-K - SeaStar Medical Holding Corp (0001831868) (Filer)

    2/16/24 8:00:10 AM ET
    $LMAO
    Consumer Electronics/Appliances
    Industrials

    SEC Form EFFECT filed by LMF Acquisition Opportunities Inc.

    EFFECT - SeaStar Medical Holding Corp (0001831868) (Filer)

    2/15/24 12:15:35 AM ET
    $LMAO
    Consumer Electronics/Appliances
    Industrials

    SEC Form S-8 filed by LMF Acquisition Opportunities Inc.

    S-8 - SeaStar Medical Holding Corp (0001831868) (Filer)

    2/9/24 4:20:19 PM ET
    $LMAO
    Consumer Electronics/Appliances
    Industrials

    $LMAO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Green David A

    3 - SeaStar Medical Holding Corp (0001831868) (Issuer)

    1/22/24 9:11:04 PM ET
    $LMAO
    Consumer Electronics/Appliances
    Industrials

    Schlorff Eric was granted 60,248 shares, increasing direct ownership by 8% to 837,823 units (SEC Form 4)

    4 - SeaStar Medical Holding Corp (0001831868) (Issuer)

    11/29/23 4:15:25 PM ET
    $LMAO
    Consumer Electronics/Appliances
    Industrials

    Chung Kevin was granted 63,422 shares, increasing direct ownership by 43% to 210,860 units (SEC Form 4)

    4 - SeaStar Medical Holding Corp (0001831868) (Issuer)

    11/29/23 4:15:01 PM ET
    $LMAO
    Consumer Electronics/Appliances
    Industrials

    $LMAO
    Leadership Updates

    Live Leadership Updates

    View All

    SeaStar Medical Appoints Dr. Sai Prasad Iyer, Ph.D as VP, Medical Affairs and Clinical Development

    Denver, Colo. and Tampa, Fla., Sept. 19, 2022 (GLOBE NEWSWIRE) -- SeaStar Medical, a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, and LMF Acquisition Opportunities, Inc. (NASDAQ:LMAO) (LMAO), a special purpose acquisition company, today announced the appointment of Dr. Sai Prasad N. Iyer, Ph.D to the position of Vice President, Medical Affairs and Clinical Development at SeaStar Medical, effective September 15, 2022. Dr. Iyer brings 20 years of industry experience and will provide leadership in developing and executing clinical trials, including SeaStar Medical's upcoming pivotal clinical trial of its Sel

    9/19/22 8:30:00 AM ET
    $LMAO
    Consumer Electronics/Appliances
    Industrials

    SeaStar Medical Appoints Kevin Chung, MD as Chief Medical Officer

    DENVER, CO and TAMPA, FL, May 24, 2022 (GLOBE NEWSWIRE) -- SeaStar Medical Inc., a medical technology company developing a platform therapy to reduce the consequences of hyperinflammation on vital organs, and LMF Acquisition Opportunities, Inc. (NASDAQ:LMAO) (LMAO), a special purpose acquisition company, today announced that Kevin Chung, MD will join SeaStar Medical as Chief Medical Officer (CMO), effective July 1, 2022. Dr. Chung brings over 20 years of experience as an accomplished critical care physician with expertise in extracorporeal life support therapies (ECLS). Since his fellowship training in critical care at Walter Reed Army Medical Center, Dr. Chung has treated thousands o

    5/24/22 8:00:00 AM ET
    $LMAO
    Consumer Electronics/Appliances
    Industrials

    $LMAO
    Financials

    Live finance-specific insights

    View All

    LM Funding Reports Net Income of $11.1 Million or $2.05 Per Basic Common Share for the Second Quarter of 2021

    TAMPA, Fla., Aug. 16, 2021 (GLOBE NEWSWIRE) -- LM Funding America, Inc. (NASDAQ:LMFA) ("LM Funding" or "LMFA"), a technology-based specialty finance company, today announced its financial results for the three and six months ended June 30, 2021. Financial Highlights for the Three and Six Month Period Ended June 30, 2021: Net income attributable to LM Funding for the three and six-month periods ended June 30, 2021 totaled $11.1 million or $2.05 per basic and diluted share and $15.5 million or $2.96 per basic and $2.95 per diluted share, respectively.Cash increased to $22.2 million or approximately $4.09 per basic and diluted share on June 30, 2021 as compared to $11.6 million

    8/16/21 4:10:00 PM ET
    $LMAO
    $LMFA
    Consumer Electronics/Appliances
    Industrials
    Finance: Consumer Services
    Finance

    $LMAO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by LMF Acquisition Opportunities Inc. (Amendment)

    SC 13G/A - SeaStar Medical Holding Corp (0001831868) (Subject)

    2/14/24 9:50:57 AM ET
    $LMAO
    Consumer Electronics/Appliances
    Industrials

    SEC Form SC 13G/A filed by LMF Acquisition Opportunities Inc. (Amendment)

    SC 13G/A - SeaStar Medical Holding Corp (0001831868) (Subject)

    8/10/23 1:29:40 PM ET
    $LMAO
    Consumer Electronics/Appliances
    Industrials

    SEC Form SC 13G/A filed by LMF Acquisition Opportunities Inc. (Amendment)

    SC 13G/A - SeaStar Medical Holding Corp (0001831868) (Subject)

    2/14/23 3:38:15 PM ET
    $LMAO
    Consumer Electronics/Appliances
    Industrials